Animal models of Mycobacterium abscessus pulmonary infection phenotypes: What are we modeling?
- PMID: 40788902
- PMCID: PMC12338768
- DOI: 10.1371/journal.ppat.1013414
Animal models of Mycobacterium abscessus pulmonary infection phenotypes: What are we modeling?
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease.Chest. 2024 Feb;165(2):288-302. doi: 10.1016/j.chest.2023.08.025. Epub 2023 Sep 3. Chest. 2024. PMID: 37661004
-
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations.Tuberculosis (Edinb). 2024 Jul;147:102503. doi: 10.1016/j.tube.2024.102503. Epub 2024 Mar 19. Tuberculosis (Edinb). 2024. PMID: 38729070 Free PMC article. Review.
-
VLX600, an anticancer iron chelator, exerts antimicrobial effects on Mycobacterium abscessus infections.Microbiol Spectr. 2025 Aug 5;13(8):e0071925. doi: 10.1128/spectrum.00719-25. Epub 2025 Jun 20. Microbiol Spectr. 2025. PMID: 40539807 Free PMC article.
-
Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally.J Vis Exp. 2025 Apr 25;(218):10.3791/67602. doi: 10.3791/67602. J Vis Exp. 2025. PMID: 40354234 Free PMC article.
-
Omadacycline therapy for Mycobacterium abscessus species infections.Intern Med J. 2023 Dec;53(12):2257-2263. doi: 10.1111/imj.16071. Epub 2023 Mar 25. Intern Med J. 2023. PMID: 36917124
References
LinkOut - more resources
Full Text Sources